|
Shelley Fussey joined Peregrine as Vice President, Intellectual Property in February 2005. Dr. Fussey will play a key role in Peregrine's US and international patenting, patent analysis and patent defense. An expert in European opposition procedures, portfolio analysis and counseling in the biotechnology arena, Dr. Fussey's expertise includes patent strategy for technologies developed both in-house and in-licensed from universities. She has broad experience in intellectual property consulting for areas as complex as cancer treatment, immunology, diabetes, and antiviral technology, as well as other areas central to pharmaceutical and biotechnology drug development. Prior to joining Peregrine, Dr. Fussey worked for the law firms of Williams, Morgan & Amerson and Arnold, White and Durkee. She holds a Ph.D. in Biochemistry, and a B.Sc. in Biochemistry with First Class Honours (Summa Cum Laude) from the University of Newcastle upon Tyne, UK. | 